Details for New Drug Application (NDA): 207021
✉ Email this page to a colleague
The generic ingredient in ZOLMITRIPTAN is zolmitriptan. There are twenty drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the zolmitriptan profile page.
Summary for 207021
Tradename: | ZOLMITRIPTAN |
Applicant: | Aurobindo Pharma |
Ingredient: | zolmitriptan |
Patents: | 0 |
Pharmacology for NDA: 207021
Mechanism of Action | Serotonin 1b Receptor Agonists Serotonin 1d Receptor Agonists |
Suppliers and Packaging for NDA: 207021
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ZOLMITRIPTAN | zolmitriptan | TABLET;ORAL | 207021 | ANDA | Rising Pharma Holdings, Inc. | 16571-803 | 16571-803-16 | 1 BLISTER PACK in 1 CARTON (16571-803-16) / 6 TABLET, FILM COATED in 1 BLISTER PACK |
ZOLMITRIPTAN | zolmitriptan | TABLET;ORAL | 207021 | ANDA | Rising Pharma Holdings, Inc. | 16571-804 | 16571-804-13 | 1 BLISTER PACK in 1 CARTON (16571-804-13) / 3 TABLET, FILM COATED in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 2.5MG | ||||
Approval Date: | May 11, 2016 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | May 11, 2016 | TE: | AB | RLD: | No |
Complete Access Available with Subscription